Iterum Therapeutics, International Limited
Quick facts
Marketed products
Phase 3 pipeline
- Sulopenem Etzadroxil/Probenecid · Infectious Diseases
Sulopenem etzadroxil/probenecid is a combination antibiotic that works by inhibiting bacterial cell wall synthesis and reducing the reabsorption of the antibiotic in the kidneys.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Iterum Therapeutics, International Limited portfolio CI brief
- Iterum Therapeutics, International Limited pipeline updates RSS
Frequently asked questions about Iterum Therapeutics, International Limited
What are Iterum Therapeutics, International Limited's marketed drugs?
Top marketed products include sulopenem etzadroxil and probenecid.
What is Iterum Therapeutics, International Limited's pipeline?
Iterum Therapeutics, International Limited has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Sulopenem Etzadroxil/Probenecid.